These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14567779)

  • 1. A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology.
    Wilson J; Rossi CP; Carboni S; Fremaux C; Perrin D; Soto C; Kosco-Vilbois M; Scheer A
    J Biomol Screen; 2003 Oct; 8(5):522-32. PubMed ID: 14567779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
    Higgins LM; McDonald SA; Whittle N; Crockett N; Shields JG; MacDonald TT
    J Immunol; 1999 Jan; 162(1):486-93. PubMed ID: 9886424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
    al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
    Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
    Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
    J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for determination of the affinity of protein: protein interactions in homogeneous assays.
    Newton P; Harrison P; Clulow S
    J Biomol Screen; 2008 Aug; 13(7):674-82. PubMed ID: 18626116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.
    Wu X; Glickman JF; Bowen BR; Sills MA
    J Biomol Screen; 2003 Aug; 8(4):381-92. PubMed ID: 14567790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.
    Matsumura Y; Hori T; Kawamata S; Imura A; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3007-11. PubMed ID: 10477563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform.
    Von Leoprechting A; Kumpf R; Menzel S; Reulle D; Griebel R; Valler MJ; Büttner FH
    J Biomol Screen; 2004 Dec; 9(8):719-25. PubMed ID: 15634799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of rat OX40 ligand by molecular cloning.
    Akiba H; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
    Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
    Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors.
    Delle Fratte S; Piubelli C; Domenici E
    J Biomol Screen; 2002 Dec; 7(6):541-6. PubMed ID: 14599352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-dependent activation of the chimeric tumor necrosis factor receptor-amyloid precursor protein (APP) reveals increased APP processing and suppressed neuronal differentiation.
    Sim PL; Heese K
    Neurosignals; 2010; 18(1):9-23. PubMed ID: 19786811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor.
    Baum PR; Gayle RB; Ramsdell F; Srinivasan S; Sorensen RA; Watson ML; Seldin MF; Clifford KN; Grabstein K; Alderson MR
    Circ Shock; 1994 Sep; 44(1):30-4. PubMed ID: 7704935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.